In this lecture, we will explore the current landscape and future directions in Alzheimer’s disease research. We’ll discuss recent breakthroughs in disease-modifying therapies, including anti-amyloid monoclonal antibodies, and examine advancements in treatments aimed at improving cognition and behavior. We’ll also look at emerging areas such as precision medicine, combination therapies, and the role of biomarkers in early detection and trial design. Additionally, we’ll cover challenges related to trial recruitment and diversity, and highlight the potential of innovative technologies like AI and digital health tools to transform Alzheimer’s research and patient care. By the end of the session, you’ll have a deeper understanding of the ongoing progress and future opportunities in this field.

 
Sign Me Up!

Presenter
Henry Tran, MD, FACC, FACP

Henry Tran is a board certified cardiologist and Assistant Professor of Medical Education (UVa.). He has over 20 years of experience in medicine. He is CEO of Sana Research which is an independent clinical trials site dedicated to neurological and cardiovascular disease trials. Dr. Tran is a fellow of the American College of Cardiology and the American College of Physicians. He has received awards for his teaching and been recognized as a “Top Doc” by Washingtonian Magazine.

Dr. Tran is committed to community service and humanitarian work. He was volunteered on several medical missions in Vietnam throughout the TranTien Foundation.  He also currently serves on the board of Insight.

Dr. Tran grew up in McLean, Va. He majored in History at the University of Virginia and then received his medical degree from Georgetown University. He completed his internal medicine residency and cardiovascular disease fellowship at NYU. In his spare time, Dr. Tran enjoys playing tennis, cooking, and running after his toddler.